Literature DB >> 1738920

Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (WF rat----B10 mouse).

Y J Zeng1, C Ricordi, A Tzakis, H L Rilo, P B Carroll, T E Starzl, S T Ildstad.   

Abstract

We recently reported that reconstitution of lethally irradiated B10 mouse recipients with 40 x 10(6) untreated WF rat bone marrow cells resulted in stable fully xenogeneic chimerism (WF rat----B10 mouse). In these animals, the tolerance induced for skin xenografts was highly MHC specific in that donor-specific WF rat skin grafts were significantly prolonged while MHC-disparate third-party xenografts were rapidly rejected (median survival time [MST] = 9 days). We have now examined whether islet cell xenografts placed under the renal capsule of chimeras rendered diabetic with streptozotocin would be accepted and remain functional to maintain euglycemia. Animals were prepared, typed for chimerism at 6 weeks, and diabetes induced with streptozotocin. Donor-specific WF (Rt1Au) islet cell xenografts were significantly prolonged (MST greater than 180 days) in WF----B10 chimeras, while MHC-disparate third-party F344 rat (Rt1A1) grafts were rejected with a time course similar to unmanipulated B10 mice (MST = 8 days). The transplanted donor-specific islet cells were functional to maintain euglycemia, since removal of the grafts at from 100 to 180 days in selected individual chimeras uniformly resulted in return of the diabetic state. These data suggest that donor-specific islet cell xenografts are accepted and remain functional in mice rendered tolerant to rat xenoantigens following bone marrow transplantation.

Entities:  

Mesh:

Year:  1992        PMID: 1738920      PMCID: PMC2963935          DOI: 10.1097/00007890-199202010-00005

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  50 in total

1.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

2.  Cyclosporin A tissue levels in a cadaveric renal allograft recipient.

Authors:  B D Kahan; C T Van Buren; M Boileau; M Ried; W D Payne; S Flechner; J Newburger
Journal:  Transplantation       Date:  1983-01       Impact factor: 4.939

3.  Successful islet transplantation in spontaneous diabetes.

Authors:  A Naji; W K Silvers; S A Plotkin; D Dafoe; C F Barker
Journal:  Surgery       Date:  1979-08       Impact factor: 3.982

4.  Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: case report of an initial attempt.

Authors:  A P Monaco; A W Clark; M L Wood; A I Sahyoun; S D Codish; R W Brown
Journal:  Surgery       Date:  1976-04       Impact factor: 3.982

5.  Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice.

Authors:  R M Steinman; M D Witmer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients.

Authors:  W H Barber; A G Diethelm; D A Laskow; M H Deierhoi; B A Julian; J J Curtis
Journal:  Transplantation       Date:  1989-01       Impact factor: 4.939

7.  Pancreatic islet transplantation after upper abdominal exenteration and liver replacement.

Authors:  A G Tzakis; C Ricordi; R Alejandro; Y Zeng; J J Fung; S Todo; A J Demetris; D H Mintz; T E Starzl
Journal:  Lancet       Date:  1990-08-18       Impact factor: 79.321

8.  Low-temperature culture of human islets or in vivo treatment with L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survival.

Authors:  C Ricordi; P E Lacy; K Sterbenz; J M Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

9.  Xenogeneic skin graft rejection is especially dependent on CD4+ T cells.

Authors:  R N Pierson; H J Winn; P S Russell; H Auchincloss
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

10.  In vivo and in vitro characterization of specific hyporeactivity to skin xenografts in mixed xenogeneically reconstituted mice (B10 + F344 rat----B10).

Authors:  S T Ildstad; S M Wren; S O Sharrow; D Stephany; D H Sachs
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Alternatives to immunosuppressive drugs in human islet transplantation.

Authors:  Alison Anne Cotterell; Norma Sue Kenyon
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

2.  Donor dendritic cell repopulation in recipients after rat-to-mouse bone-marrow transplantation.

Authors:  C Ricordi; S T Ildstad; A J Demetris; A Y Abou el-Ezz; N Murase; T E Starzl
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

Review 3.  Cellular transplantation and gene therapy.

Authors:  C Ricordi; S T Ildstad; T E Starzl
Journal:  Clin Transplant       Date:  1993-02       Impact factor: 2.863

4.  Islet xenografts in fully xenogeneic (rat----mouse) chimeras: evidence for normal regulation of function in a xenogeneic mouse environment.

Authors:  C Ricordi; Y Zeng; P B Carroll; H L Rilo; D R Beretier; T E Starzl; S T Ildstad
Journal:  Surgery       Date:  1992-08       Impact factor: 3.982

5.  Donor bone marrow cell infusion without recipient cytoablation induces acceptance of rat islet allografts.

Authors:  C Ricordi; N Murase; C Rastellini; R Behboo; A J Demetris; T E Starzl
Journal:  Transplant Proc       Date:  1994-12       Impact factor: 1.066

6.  Indefinite survival of rat islet allografts following infusion of donor bone marrow without cytoablation.

Authors:  C Ricordi; N Murase; C Rastellini; R Behboo; A J Demetris; T E Starzl
Journal:  Cell Transplant       Date:  1996 Jan-Feb       Impact factor: 4.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.